The U.S. IPO market remained strong this year in terms of issuer and dollar volume.
Corporate defined benefit plans are seen accelerating the trend to heavier fixed-income allocations.
SPAC IPO issuance has cooled after last year's torrid pace, which included SPACs backed by KKR & Co. and Thoma Bravo.
Yale is shifting its allocation toward leveraged-buyout and venture-capital strategies to improve risk-adjusted returns.
Exxon Mobil has spent a lot to return cash to shareholders over the years.